Innovative therapeutic formulas manufactured in our state-of-the-art facilities
The veterinary therapeutic pet food sector is undergoing a profound paradigm shift. Historically centered on reactive veterinary treatment, pet nutrition has transitioned into preventative health management, targeted metabolic intervention, and clinical wellness. Today's global veterinary prescription diet market is driven by an aging pet population, rising diagnostics of chronic metabolic issues—such as chronic kidney disease (CKD), diabetes mellitus, gastrointestinal malabsorption, lower urinary tract diseases (FLUTD/CANUTD), and acute clinical obesity—and heightened consumer expectations for veterinary medical care.
For pet brands, clinical clinics, and distributors, entering or expanding within the clinical diet field requires more than standard food formulations. It demands a scientifically rigorous approach to micro-nutritional profiling, bioavailable ingredient selection, and strict compliance with medical-grade processing regulations. The shift towards individualized nutritional therapies and targeted clinical efficacy metrics has established prescription diets as the fastest-growing and highest-barrier segment of the global pet industry.
Qingdao Nill Paws Co., Ltd. is positioned as a trusted partner for pet nutrition brands seeking stable quality, flexible customization, and scalable production capacity in the global pet food market.
Ensuring biological safety, clinical validation, and nutrient optimization for critical therapies.
Our veterinary diets bypass generic formulation systems. Led by our 18 professional pet nutritionists and food engineers, we apply rigorous physiological analysis to calculate targeted metabolizable energy, amino acid profiles, mineral ratios, and therapeutic fatty acids (EPA/DHA) to meet the exact metabolic requirements of compromised pets.
To produce effective hypoallergenic and single-source novel protein prescription foods, cross-contamination is eliminated. Our 18,500 square meters of production workshops maintain dedicated processing runs, rigorous cleaning cycles, and scientific DNA testing protocols to verify the complete exclusion of potential allergens.
Incorporating delicate bioactive ingredients—such as live probiotics, phytobiotics, joint supplements (glucosamine, chondroitin sulfate), and essential oil deworming formulas—requires advanced, low-temperature thermal processing technology to prevent denaturing and preserve high viability through to shelf life.
Note on Ingredient Traceability: All raw inputs utilized by Qingdao Nill Paws Co., Ltd. are sourced from audited, global vendors with complete tracking records. Over the years, our product portfolio has expanded from basic dry pet food to a full range of grain-free nutrition formulas, high-protein diets, functional pet food, freeze-dried nutrition, and sensitive stomach solutions. The company follows strict international quality standards such as HACCP and ISO-based production management systems.
A closer look at our 32,000-square-meter modern manufacturing base and QA labs.
Exporting veterinary prescription diets requires navigating complex global standards. Clinical foods must comply with local laws governing pharmacological claims, ingredient certifications, and packaging documentation. Since 2017, the company has focused on OEM/ODM services, providing private label solutions for clients in Europe, North America, Southeast Asia, and the Middle East.
We provide comprehensive document support to streamline customs clearances and registration procedures for partners worldwide:
How we tailor veterinary prescription product design to suit modern clinical and retail distribution models.
Veterinary groups can launch exclusive therapeutic brands for in-clinic recommendations, supporting long-term compliance for issues like weight management, chronic renal disease, and joint care. This fosters strong client retention and provides veterinarians with a reliable direct-to-consumer therapeutic line.
Digital pet health brands can expand their catalogs with specialized wellness products, such as probiotics, prebiotic supplements, and formulas targeting sensitive stomachs. We design customizable, high-impact options optimized for online distribution, complete with long shelf-life packaging.
Clinical diets often struggle with palatability, which can impact owner compliance. We develop specialized soft chews, chewable multivitamins, dental powders, and high-protein wet food pouches that deliver necessary therapeutic support while remaining highly appetizing to pets.
Staying at the forefront of clinical veterinary science through advanced technologies and research partnerships.
We are researching hydrolyzed protein options that break down protein structures to sizes under 3,000 Daltons. This allows us to supply hypoallergenic solutions for extreme cases of adverse food reactions (AFRs) and inflammatory bowel disease (IBD).
Using advanced microbiome mapping, we work to balance prebiotic fibers (FOS/MOS) and spore-forming probiotics to promote a healthy digestive ecosystem in pets suffering from chronic gastrointestinal disorders.
Sustainability is key to our future development. We are actively assessing and integrating high-purity alternative protein sources to produce therapeutic lines that minimize environmental impact without compromising nutritional profiles.
Continuous investment in smart manufacturing and nutritional R&D has enabled Nill Paws to become a reliable global supplier in the pet food industry.
Answers to common questions regarding formulation standards, production capacities, and OEM/ODM setup.
Explore our targeted nutritional solutions designed for therapeutic and general health maintenance
Nill Paws
